AnodyneWiki

Ergotamine

Ergotamine
Ergotamine
Salts
[]
Ergotamine hemitartrate
Ergotamine hemitartrate
Molecular structure drawn from PubChem coordinates
Rotamer
[]
Conformer structure via 3Dmol.js
Enable javascript to view conformer structure via 3Dmol.js
Physical properties
[]
Molecular mass581.70 g/mol [1]
AppearanceNeedles from alcohol; prisms from benzene; plates from acetone [1]
Melting point213.5 dec °C [1]
DecompositionDecomposition at 212-214 °C. [1]
SolubilitySlight [1]
Predicted LogP2 [1]
Structural Identifiers
[]
Molecular formulaC33H35N5O5
IUPAC name(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
SMILESC[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C
InChIInChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1
InChIKeyXCGSFFUVFURLIX-VFGNJEKYSA-N
CAS number113-15-5
UNIIPR834Q503T
PubChem CID8223
Pharmacokinetics[]
Elimination half-life2 hours
MetabolismLiver
Excretion90% Bile duct
Routes of administrationOral
Toxicity
[]
Cat:
- sc: 11 mg/kg
Mouse:
- iv: 62 mg/kg
Rabbit:
- iv: 100 mg/kg
- iv: 3 mg/kg
Rat:
- iv: 80 mg/kg
- Intravenous: 62 mg/kg
 [1]

Ergotamine (also known as Ergotamin, Ergonsvine, Ergotamina, ergotaminum, 12'-Hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione, (5'α)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione, Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-α)-, Ergo Kranit, Mono, Ergodryl or N02ca02) is a substance of the lysergamide class.

Chemistry

Salts []

Ergotamine is typically found in the form of its hemitartrate salt.

 []

Ergotamine is a single defined stereoisomer.

Ergotamine matches Lipinski's rule of five (violations: 1).

Pharmacology

Mechanism of action []

Ergotamine acts on migraine by one of two proposed mechanisms: 1) activation of 5-HT<sub>1D</sub> receptors located on intracranial blood vessels, including those on arterio-venous anastomoses, leads to vasoconstriction, which correlates with the relief of migraine headache, and 2) activation of 5-HT<sub>1D</sub> receptors on sensory nerve endings of the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / induction / inhibition147 (7 contraindicated)
shared target18 (2 contraindicated)
shared target18 (2 contraindicated)
shared target18 (2 contraindicated)
shared target14 (12 contraindicated)
shared target14 (12 contraindicated)
shared target10

Medical side effects []

22 side effects listed on drug labels in (ergotamine).

  • Asthenia
  • Cyanosis
  • Localised oedema
  • Gangrene
  • Hypertension
  • Ischaemia
  • Nausea
  • Hypoaesthesia
  • Sensory loss
  • Pain
  • Paraesthesia
  • Paresthesia of limbs
  • Pruritus
  • Tachycardia
  • Vertigo
  • Vomiting
  • Emotional distress
  • Myalgia
  • Musculoskeletal discomfort
  • Pulse absent
  • Peripheral coldness
  • Bradycardia

Indications

  • Headache
  • Migraine
  • Variants of migraine
  • Vascular headache

 []

  • Australia: Ergotamine is a Schedule 4.
  • Brazil: Ergotamine is a D1.[3]
  • Canada: Ergotamine is a Schedule VI.
  • United Kingdom: Ergotamine is Prescription only.
  • United States: Ergotamine is Prescription only.[4][5]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 8223, Ergotamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/8223
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Ergotamine. UNII: PR834Q503T. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/PR834Q503T
  3. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
  4. Ergomar- ergotamine tartrate tablet, orally disintegrating. DailyMed. 8 September 2012. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bfd4827-5123-4dbb-8f94-7b097f5bfd5c
  5. Ergomar sublingual- ergotamine tartrate tablet. DailyMed. 25 October 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dac9637f-3326-4f25-b7b9-f9f54b738232

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 03:05:31
drugspromissing (no DrugsPRO reagent data)2026-11-20 03:05:27
erowidmissing (no Erowid substance of that name)2026-11-20 03:05:27
gsrsok2026-11-20 03:05:28
hmdbmissing (hmdb.ca refused automated access to HMDB0014834)2026-11-20 03:05:27
keggok2026-11-20 03:05:29
pubchemok2026-11-20 03:05:26
redditmissing (no r/tripreports posts mention it)2026-11-20 03:05:27
siderok2026-11-20 03:05:27
structureok2026-11-20 03:05:27
wikipediaok2026-11-20 03:05:27